Apalutamide Recruiting Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03009981A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer